Introduction
Discontinuations of
HIV
preexposure prophylaxis (Pr
EP
) by at‐risk individuals could decrease the effectiveness of Pr
EP
. Our objective was to characterize patterns of, reasons for, and clinical outcomes associated with Pr
EP
discontinuations in primary care.
Methods
We conducted medical chart reviews for patients prescribed Pr
EP
during 2011 to 2014 at a Boston community health centre specializing in healthcare for sexual and gender minorities. Patients were followed through 2015. We characterized patients’ sociodemographics, relationship status, behavioural health conditions, patterns of and reasons for Pr
EP
discontinuations, and
HIV
seroconversions. Cox proportional hazards models were used to assess patient factors associated with Pr
EP
discontinuations.
Results
Of the 663 patients prescribed Pr
EP
, the median age was 33 years, 96% were men who have sex with men (
MSM
) and 73% were non‐Hispanic white; 40% were in committed relationships and 15% had
HIV
‐infected partners. Patients either used Pr
EP
continuously (60%), had 1 or more discontinuations (36%), or did not initiate Pr
EP
(4%). Discontinuations were most often due to a decrease in
HIV
risk perception (33%), non‐adherence to care plans (16%), or insurance barriers (12%). Of the 7 (1.1%) Pr
EP
patients diagnosed with
HIV
, 1 was
HIV
‐infected at baseline, 2 seroconverted while using Pr
EP
, and 4 seroconverted after discontinuations. In a multivariable model adjusted for race/ethnicity, relationship status, substance use disorders, and insurance status, those who were less than 30 years old (
aHR
2.0, 95%
CI
1.4 to 2.9 for ages 18 to 24,
aHR
2.2, 95%
CI
1.6 to 3.1 for ages 25 to 29, vs. ages 30 to 39 years), who identified as transgender women (
aHR
2.0, 95%
CI
1.2 to 3.4, vs. cisgender men), and who had mental health disorders (
aHR
1.2, 95%
CI
1.1 to 1.4 for each additional disorder) were more likely to have discontinuations.
Conclusions
Discontinuations of Pr
EP
use among this American sample of predominately
MSM
were common, particularly among patients who were younger, identified as transgender women, or had behavioural health issues. As
HIV
...